🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT05476523
Recruiting Observational

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

NCT05476523 · tracked via the Priya Life Science USA tracker
Sponsor
NeuraLight
Phase
Observational
Started
2022-07-22
Last updated
2025-05-20

Condition(s) studied

Eye Movement

Investigational drug(s) / intervention(s)

NeuraLight

NeuraLight: NeuraLight is an investigational software-based platform used for measuring eye movements in response to visual stimuli and captured using a simple webcam

Study summary

This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Men and women ages between 18 and 90 years old * Normal or corrected vision * Ability to follow instructions * Willing and able to sign an informed consent form Exclusion Criteria: * Inability to sit for 20 minutes on a chair in a calm manner * Personal or 1st degree relative history of epilepsy * Additional neurological diseases * Drug or alcohol abuse

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
NeuraLight Wilmington Delaware Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05476523 on ClinicalTrials.gov ↗ ← All trials in the USA